Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
about
Therapeutic advances in the treatment of vasculitisDiagnostic approach and current treatment options in childhood vasculitisAdenosine Deaminase Deficiency - More Than Just an ImmunodeficiencyNewly recognized Mendelian disorders with rheumatic manifestationsMonogenic polyarteritis: the lesson of ADA2 deficiencyChildhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysisGastrointestinal aspects of vasculitides.Loss of function of PCDH12 underlies recessive microcephaly mimicking intrauterine infectionEarly-onset stroke and vasculopathy associated with mutations in ADA2Genetics, genomics, and their relevance to pathology and therapy.Mutations in CECR1 associated with a neutrophil signature in peripheral bloodCutaneous polyarteritis nodosa successfully treated with topical diflucortolone valerate: a case report & review of the literature.When less is more: primary immunodeficiency with an autoinflammatory kickNovel primary immunodeficiency candidate genes predicted by the human gene connectomeA novel association of adenosine deaminase with paroxysmal atrial fibrillation: a propensity score analysis from a case-control studyUnexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiencyLinking classification and therapeutic management of vasculitides.New monogenic autoinflammatory diseases--a clinical overviewMolecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.ADA2 deficiency: case report of a new phenotype and novel mutation in two sistersAssessment of Type I Interferon Signaling in Pediatric Inflammatory Disease.Inborn errors of metabolism underlying primary immunodeficiencies.Vasculitis: do we know more to classify better?Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.Human disease phenotypes associated with mutations in TREX1.Venous thromboembolism in systemic autoimmune diseases: A narrative review with emphasis on primary systemic vasculitides.Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years.Innate immune cells in the pathogenesis of primary systemic vasculitis.Pharmacological approaches to CNS vasculitis: where are we at now?Vasculitis update: pathogenesis and biomarkers.Recurrent Fevers for the Pediatric Immunologist: It's Not All Immunodeficiency.Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.Genetically defined autoinflammatory diseases.Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.Germline mutations predisposing to diffuse large B-cell lymphoma.CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner.Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood.Kidney involvement in medium- and large-vessel vasculitis.A Case of Polyarteritis Nodosa Associated with Vertebral Artery Vasculitis Treated Successfully with Tocilizumab and Cyclophosphamide.
P2860
Q26750499-7C4A5FB5-01CB-4603-93C1-B42C9C8B3607Q26765359-FD919AB0-ABB0-4699-B80E-6ADEA2537951Q26865373-180277D3-A38D-4CEF-B6F7-AEEA6DFF2FB2Q26996730-D5D9670C-4108-44DC-884C-146A018E1C09Q28067372-00164E35-9E79-458A-84F2-8B10E548714AQ28069646-271AD038-36CC-4911-9ACD-6F3774DD1266Q30240787-14F35094-3FA5-425D-849E-4B27AC4A4604Q30355867-5872F697-E25E-4A94-99B8-5A4402E689E9Q30410263-E6DD62E2-5B3E-472D-A719-E2B114DFCC5CQ34108958-92AAB125-0155-48A5-B488-80363D4ACA3BQ34272909-141767D7-F2FA-42F8-BAA8-E772B2A3B931Q34355296-723B12A1-629F-4599-A4CE-9B0BD426A951Q34420031-E559F73D-D32C-46B6-BFA8-E33BC38D781CQ35238656-DCD12068-F80F-4F5D-A24D-BDF3C80EE3A6Q35568298-0BBFB373-2AF6-4E5A-A8F7-1B126012BECBQ35639959-68F84EAA-1DFD-403F-9AC2-A56028038000Q35672892-42A10B0F-FA10-425A-9C76-3A07EE7ECC32Q36016335-8C7E689E-B042-4943-9979-572E345672AFQ36041225-74D28904-F9D3-48A3-9409-DDA8DA42C9C6Q36933267-9662418D-A686-4258-B48E-63395F92BA99Q37666293-D6FA8C83-D7FC-49F9-BD93-6713C9B673F8Q38235840-DD85BE5C-9E13-4F3B-827B-DC8BD13C17C1Q38284032-71D96FE0-4BC3-48D1-BBBA-8864BA0DD701Q38300451-9361318D-33E0-4AE2-AFC3-F916A10D4E27Q38366756-04826FF0-CE53-4DDD-AAF0-40745DA77751Q38370197-2C408E26-5EEE-435A-BBA3-1603FD58779DQ38414568-C89C229A-D72B-4D88-BEB6-E64153518A4AQ38592346-B820F441-80B5-4160-B88F-B7E28D66D1DAQ38630819-09F133EC-D9C5-4285-AA47-EFDF19A75C79Q38645654-6A94136B-3E53-455A-BB7A-4FDD3D4343D3Q38680309-D4B42A73-CA82-4A04-AE57-85262124EC4CQ38705689-B102ADB7-BA7D-4F12-A861-EF3E65224226Q38720044-0837D5BE-7154-4694-9B2C-0449298354C5Q38746358-5EFA9609-F8AD-4BF2-8E41-5BA1F871D24AQ38756189-034FC783-5595-4A8C-BAB5-E32B58545110Q38769439-88D2A878-3487-4DA8-8054-D0F099122706Q38773387-2FC6B434-4A62-426A-9DEB-65D61B2A87D4Q38792367-AC8ED926-37AA-47E0-B9F1-AC920F6A2E38Q38813388-E47D1C1E-569D-4295-BEC3-0CCFA8CC2159Q38888407-9B4DB006-D9BC-4126-967F-29A4BA9A6896
P2860
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
@ast
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
@en
type
label
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
@ast
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
@en
prefLabel
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
@ast
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
@en
P2093
P50
P356
P1476
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
@en
P2093
Abraham Zlotogorski
Alan Rubinow
Amihood Singer
Ariella Weinberg-Shukron
Dina Marek-Yagel
Eduard Ling
Elif F Sener
Fatos Yalcinkaya
Isabel Voth
P304
P356
10.1056/NEJMOA1307362
P407
P50
P577
2014-02-19T00:00:00Z